Jonathan M. Brunger*
-
Coupling of IL-1β and Collagen II Targeting Antibodies using the SpyMask System
A bispecific protein designed to inhibit IL-1β while targeting type II collagen to localize anti-inflammatory therapy in osteoarthritis. -
Optimization of Expression and Purification of an Anti-Inflammatory Binding Motif
This study outlines the development of a protocol for producing codon-optimized Gevokizumab scFv to hinder IL-1β activation, with findings that suggest enhanced protein expression in optimized constructs, which paves the way for potential therapeutic applications in inflammatory diseases. -
The Development of synNotch-Engineered Pluripotent Stem Cells for Synthetic Morphogenesis
Synthetic Notch (synNotch)-engineered H9 hESCs displayed high receptor expression, adhered and activated on an engineered substratum, and induced early gastrulation differentiation via synNotch-regulated WNT signaling. -
Ligand Dose Response for Different Affinity Synthetic Receptors on an Engineered Biomaterial Surface
Utilizing the synNotch synthetic receptor platform, we tested two different affinity GFP responsive receptors to understand their activa-tion thresholds for purpose of developing a platform for regenerative engineering. -
Global Patent Landscape of Induced Pluripotent Stem Cells
Review and analysis of worldwide patent literature regarding induced pluripotent stem cells.